Search

Displaying results 4891 - 4900 of 5392 in total
  1. Drug

    Atigliflozin

    go.drugbank.com/drugs/DB21394
    Investigational

    Atigliflozin has a monoisotopic molecular weight of 382.11 Da.

  2. Drug

    Lifibrate

    go.drugbank.com/drugs/DB21399
    Experimental

    Lifibrate has a monoisotopic molecular weight of 409.08 Da.

  3. Drug

    Dazdotuftide

    go.drugbank.com/drugs/DB21550
    Investigational

    Dazdotuftide has a monoisotopic molecular weight of 1005.48 Da.

  4. Drug

    Muvalaplin

    go.drugbank.com/drugs/DB21568
    Investigational

    Muvalaplin has a monoisotopic molecular weight of 710.4 Da.

  5. Drug

    Pocenbrodib

    go.drugbank.com/drugs/DB21616
    Investigational

    Pocenbrodib has a monoisotopic molecular weight of 525.23 Da.

  6. Drug

    Upleganan

    go.drugbank.com/drugs/DB21618
    Investigational

    Upleganan has a monoisotopic molecular weight of 1143.6 Da.

  7. Drug

    Levamisole

    go.drugbank.com/drugs/DB00848
    ApprovedInvestigationalVet approvedWithdrawn

    [A178117, A178123] Levamisole was withdrawn from the American market in 2000 due to its ability to cause serious adverse effects, including agranulocytosis.

  8. Drug

    Tolbutamide

    go.drugbank.com/drugs/DB01124
    Approved

    Due to their mechanism of action, sulfonylureas may cause hypoglycemia and require consistent food intake to decrease this risk.

  9. Drug

    Vonoprazan

    go.drugbank.com/drugs/DB11739
    ApprovedInvestigational

    Unlike proton-pump inhibitors, PCABs are not affected by CYP2C19 genetic polymorphisms and do not require acid-resistant formulations.

  10. Drug

    Isavuconazonium

    go.drugbank.com/drugs/DB06636
    ApprovedInvestigational

    Due to low solubility in water of isavuconazole on its own, the isovuconazonium formulation is favorable as it has high solubility in water and allows for intravenous administration.